Thus transcriptional deficiency in the YG8sR mouse model is largely due to FXN promoter silencing, which leads to deficiency of transcriptional initiation, similar to lymphoblastoid cell lines from FRDA patients. The gene discussed is FXN; the disease is Friedreich ataxia.